Deletion 2q37: An identifiable clinical syndrome with mental retardation and autism

Journal of Child Neurology

Volumn 23, Issue 7, 2008, Pages 802-806

  Galasso, Cinzia ^a   Lo Castro, Adriana ^a   Lalli, Cristina ^a   Nardone, Anna Maria ^a   Gullotta, Francesca ^a   Curatolo, Paolo ^a  

^a UNIVERSITY OF ROME TOR VERGATA   (Italy)

Author keywords

2q deletion syndrome; Autism; Chromosome 2q syndrome; Mental retardation; Monosomy 2q

Indexed keywords

ARTICLE; AUTISM; AUTOMUTILATION; BACTERIAL ARTIFICIAL CHROMOSOME; CASE REPORT; CHROMOSOME 2Q; CHROMOSOME DELETION; CHROMOSOME DELETION 2; CHRONIC DISEASE; CLINICAL FEATURE; COLITIS; CYTOGENETICS; DEVELOPMENTAL DISORDER; ECHOLALIA; ELECTROENCEPHALOGRAM; FEMALE; FLUORESCENCE IN SITU HYBRIDIZATION; GASTROESOPHAGEAL REFLUX; GASTROINTESTINAL MALFORMATION; HUMAN; HYPERACTIVITY; JOINT LAXITY; KARYOTYPE; LORDOSIS; LOW BIRTH WEIGHT; LUMBAR SPINE; MENTAL DEFICIENCY; MUSCLE HYPOTONIA; PERSEVERATION; PRIORITY JOURNAL; PSYCHOLOGICAL RATING SCALE; RETROGNATHIA; SCHOOL CHILD; SLOW BRAIN WAVE; SOCIAL ADAPTATION; VALGUS DEFORMITY; VALGUS KNEE;

ABNORMALITIES, MULTIPLE; AUTISTIC DISORDER; CHILD; CHROMOSOME DELETION; CHROMOSOMES, HUMAN, PAIR 2; FEMALE; HUMANS; MENTAL RETARDATION; SYNDROME;

EID: 47349100150     PISSN: 08830738     EISSN: None     Source Type: Journal    
DOI: 10.1177/0883073808314150     Document Type: Article

References (31)

1. Casas KA, Mononen TK, Mikail CN, et al. Chromosome 2q terminal deletion: report of 6 new patients and review of phenotype-breakpoint correlations in 66 individuals. Am J Med Genet A. 2004; 130:331-339.
2. Coldwell JG, Gucsavas M., Say B., Carpenter NJ An infant with karyotype 46,XX, del(2)(q37) and congenital malformations. Hum Genet Suppl. 1992; 51:A301.
3. Conrad B., Dewald G., Christensen E., et al. Clinical phenotype associated with terminal 2q37 deletion. Clin Genet. 1995; 48:134-139.
4. Ghaziuddin M., Burmeister M. Deletion of chromosome 2q37 and autism: A distinct subtype? J Autism Dev Disord. 1999; 29:259-263.
5. Lukusa T., Vermeesch JR, Holvoet M., Fryns JP, Devriendt K. Deletion 2q37.3 and autism: Molecular cytogenetic mapping of the candidate region for autistic disorder. Genet Couns. 2004; 15:293-301.
6. Sherr EH, Owen R., Albertson DG, et al. Genomic microarray analysis identifies candidate loci in patients with corpus callosum anomalies. Neurology. 2005; 65:1496-1498.
7. Smith M., Escamilla JR, Filipek P., et al. Molecular genetic delineation of 2q37.3 deletion in autism and osteodystrophy: Report of a case and new markers for deletion screening by PCR. Cytogenet Cell Genet. 2001; 94:15-22.
8. Gorski JL, Cox BA, Kyine M., Uhlmann W., Glover TW Terminal deletion of the long arm of chromosome 2 in a mildly dysmorphic hypotonic infant with karyotype 46,XY,del(2)(q37). Am J Med Genet. 1989; 32:350-352.
9. Batstone PJ, Simpson S., Bonthron DT, et al. Effective monosomy or trisomy of chromosomes band 2q37.3 due to the umbalanced segregation of a 2;11 translocation. Am J Med Genet. 2003; 118A:241-246.
10. Bijlsma EK, Aalfs CM, Sluitjer S., et al. Familiar cryptic translocation between chromosomes 2qter and 8qter: Further delineation of the Albright hereditary osteodystrophy-like phenotype. J Med Genet. 1999; 36:604-609.
11. Chaabouni M., Le Merrer M., Raoul O., et al. Molecular cytogenetic analysis of five 2q37 deletions: Refining the brachydactyly candidate region. Eur J Med Genet. 2006; 49:255-263.
12. Fisher AM, Ellis KH, Browne CE, et al. Small terminal deletions of the long arm of chromosome 2: Two new cases. Am J Med Genet. 1994; 53:366-369.
13. Lehman NL, Zaleski DH, Sanger WG, Adickes ED Holoprosencephaly associated with an apparent isolated 2q37.1 → 2q37.3 deletion. Am J Med Genet. 2001; 100:179-181.
14. Lin S.-P, Petty EM, Gibson LH, et al. Smallest terminal deletion of the long arm of chromosome 2 in a mildly affected boy. Am J Med Genet. 1992; 44:500-502.
15. Phelan MC, Rogers RC, Clakson KB, et al. Albright hereditary osteodystrophy and del(2)(q37.3) in four unrelated individuals. Am J Med Genet. 1995; 58:1-7.
16. Power MM, James RS, Barber JCK, et al. RDCI, the vasoactive intestinal peptide receptor candidate gene for the features of Albright hereditary osteodystrophy associated with deletion of 2q37. J Med Genet. 1997; 34:287-290.
17. Rauch A., Pfeiffer RA, Trautmann U. Deletion or triplication of the α 3(VI) collagen gene in three patients with 2q37 chromosome aberrations and symptoms of collage-related disorders. Clin Genet. 1996; 49:279-285.
18. Reddy KS, Flannery D., Farrer RJ Microdeletion of chromosome sub-band 2q37.3 in two patients with abnormal situs viscerum. Am J Med Genet. 1999; 84:460-468.
19. van Karnebeek CDM, Koevoets C., Sluijter S., et al. Prospective screening for subtelomeric rearrangements in children with mental retardation of unknown aetiology: The Amsterdam experience. J Med Genet. 2002; 39:546-553.
20. Viot-Szoboszlai G., Amiel J., Doz F., et al. Wilms' tumor and gonadal dysgenesis in child with the 2q37.1 deletion syndrome. Clin Genet. 1998; 53:278-280.
21. Wang T.-H, Johnston K., Hsieh C.-L, Dennery PA Terminal deletion of the long arm of chromosome 2 in a premature infant with karyotype: 46,XY,del(2)(q37). Am J Med Genet. 1994; 49:399-401.
22. Wilson LC, Leverton K., Oude Luttikhuis MEM, et al. Brachydactyly and mental retardation: An Albright hereditary osteodystrophy-like syndrome localized to 2q37. Am J Hum Genet. 1995; 56:400-407.
23. Wolff DJ, Clifton K., Karr C., Charles J. Pilot assessment of the subtelomeric regions of children with autism: Detection of a 2q deletion. Genet Med. 2002; 4:10-14.
24. Wassink TH, Piven J., Vieland VJ, et al. Evaluation of the chromosome 2q37.3 gene CENTG2 as an autism susceptibility gene. Am J Med Genet B Neuropsychiatr Genet. 2005; 136:36-44.
25. Waters ST, Lewandoski M. A threshold requirement for Gbx2 levels in hindbrain development. Development. 2006; 133:1991-2000.
26. Imgsac. A genome wide screen for autism: Strong evidence for linkage to chromosome 2q, 7q and 16p. Am J Hum Genet. 2001; 69:570-581.
27. Yonekawa Y., Harada A., Okada Y., et al. Defect in synaptic vesicle precursor transport and neuronal cell death in KIF1A motor protein-deficient mice. J Cell Biol. 1998; 141:431-441.
28. Koyano-Nakagawa N., Kim J., Anderson D., Kintner C. Hes6 acts in a positive feedback loop with the neurogenins to promote neuronal differentiation. Development. 2000; 127:4203-4216.
29. Gratton MO, Torban E., Jasmin SB, et al. Hes6 promotes cortical neurogenesis and inhibits Hes1 transcription repression activity by multiple mechanisms. Mol Cell Biol. 2003; 23:6922-6935.
30. Raddatz R., Wilson AE, Artymyshyn R., et al. Identification and characterization of two neuromedin U receptors differentially expressed in peripheral tissues and the central nervous system. J Biol Chem. 2000; 275:32452-32459.
31. Brighton PJ, Szekeres PG, Gary BW Neuromedin U and its receptors: structure, function, and physiological roles. Pharmacol Rev. 2004; 56: 231-248.